Nisa Investment Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.24K | Buy |
2,363
+1,373
| +139% | +$3.63K | ﹤0.01% | 2405 |
|
|
2025
Q1 | $2.98K | Buy |
990
+639
| +182% | +$1.92K | ﹤0.01% | 2368 |
|
|
2024
Q4 | $899 | Sell |
351
-49
| -12% | -$126 | ﹤0.01% | 2707 |
|
|
2024
Q3 | $1.49K | Buy |
400
+86
| +27% | +$320 | ﹤0.01% | 2480 |
|
|
2024
Q2 | $1.98K | Buy |
314
+118
| +60% | +$746 | ﹤0.01% | 2376 |
|
|
2024
Q1 | $1.05K | Buy |
196
+126
| +180% | +$677 | ﹤0.01% | 2361 |
|
|
2023
Q4 | $351 | Sell |
70
-163
| -70% | -$817 | ﹤0.01% | 2474 |
|
|
2023
Q3 | $394 | Buy |
+233
| New | +$394 | ﹤0.01% | 2563 |
|
|
2023
Q1 | – | Sell |
-117
| Closed | -$1K | – | 2597 |
|
|
2022
Q4 | $1K | Sell |
117
-5,043
| -98% | -$43.1K | ﹤0.01% | 2444 |
|
|
2022
Q3 | $27K | Buy |
+5,160
| New | +$27K | ﹤0.01% | 1965 |
|
|
2022
Q2 | – | Sell |
-1,600
| Closed | -$9K | – | 2430 |
|
|
2022
Q1 | $9K | Buy |
+1,600
| New | +$9K | ﹤0.01% | 2232 |
|
|
2021
Q1 | – | Sell |
-19,500
| Closed | -$260K | – | 2306 |
|
|
2020
Q4 | $260K | Buy |
+19,500
| New | +$260K | ﹤0.01% | 1363 |
|
|
2017
Q3 | – | Sell |
-12,700
| Closed | -$100K | – | 1852 |
|
|
2017
Q2 | $100K | Buy |
+12,700
| New | +$100K | ﹤0.01% | 1346 |
|